Polymorphism of the CD14 gene in perennial allergic rhinitis

Korea University, Sŏul, Seoul, South Korea
International Journal of Pediatric Otorhinolaryngology (Impact Factor: 1.32). 12/2006; 70(12):2081-5. DOI: 10.1016/j.ijporl.2006.07.024
Source: PubMed

ABSTRACT Allergic diseases have strong genetic backgrounds. Recently, a C-T polymorphism in the promoter region of CD14 has been associated with phenotypes of atopy in some populations. The aim of this study was to investigate the association of CD14/-159 polymorphism with total serum IgE levels and number of positive skin prick tests in Korean population with perennial allergic rhinitis.
Prospective study.
Deoxyribonucleic acid obtained from 164 children with perennial allergic rhinitis and 160 healthy controls were typed for the promoter polymorphism of CD14 gene at position -159 by restriction fragment length polymorphism analysis. Genotype frequencies, total serum IgE levels, and the number of positive skin tests for each genotype were compared.
There were no significant differences in the CD14/-159 genotype frequencies between the allergic rhinitis group and the control group. In the skin prick test-positive population, the CC homozygotes were associated with higher serum total IgE levels and greater number of positive skin tests compared with subjects with CT and TT alleles (P<0.05).
The results from the present study suggest that CD14/-159 polymorphism may play a role in the development of perennial allergic rhinitis in Korean children.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The -159C/T polymorphism in the CD14 gene has been implicated in susceptibility to allergic rhinitis (AR), but results were conflicting. The aim of this study is to investigate the association between the CD14-159C/T polymorphism and the risk of AR. All eligible case-control studies published up to July 2013 were identified by searching PubMed, Web of Science and CNKI. Pooled odds ratio with 95 % confidence interval (95 % CI) was used to access the strength of this association in fixed- or random-effects model. A total of seven case-control studies, including 887 cases and 889 controls, were selected. Overall, no significant association between the CD14-159C/T polymorphism and AR risk was found. Besides, stratified analysis with ethnicity and source of control also indicated that no significant association between CD14-159C/T and the risk of AR under all for genetic model was observed. This meta-analysis indicated that the CD14-159C/T polymorphism is not associated with AR risk.
    Archives of Oto-Rhino-Laryngology 10/2013; 271(6). DOI:10.1007/s00405-013-2793-5 · 1.61 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cluster of differentiation 14 (CD14) gene is an important component of the human innate immune system and its role in tuberculosis (TB) has been sparsely documented. The enhanced plasma CD14 levels in TB patients as compared to healthy controls are associated with CD14 gene promoter (C-159T) polymorphism. In the past few years, the relationship between CD14 -159 C>T (rs2569190) polymorphism and risk of TB has been reported in various ethnic populations; however, those studies have yielded contradictory results. In this study systemic assessment was done for the published studies based on the association between CD14 -159 C>T polymorphism and TB risk retrieved from PubMed (Medline) and EMBASE search. A total number of 1389 TB cases and 1421 controls were included in this study and meta-analysis was performed to elucidate the association between CD14 -159 C>T polymorphism and its susceptibility towards TB. Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for allele contrast, homozygous comparison, heterozygous comparison, dominant and recessive genetic model. It was found that T allele carrier was significantly associated with increased TB risk (T vs. C: p-value = 0.023; OR = 1.305, 95% CI = 1.038 to 1.640). Similarly, homozygous mutant TT genotype also revealed 1.6 fold increased risk of TB (TT vs. CC; p-value = 0.040; OR = 1.652, 95% CI = 1.023 to 2.667). Additionally, dominant genetic model demonstrated increased risk of developing TB (TT vs. CC+CT: p-value = 0.006; OR = 1.585, 95% CI = 1.142 to 2.201). The study demonstrates that CD14 gene (-159 C>T) polymorphism contributes increased susceptibility for TB. Moreover, this meta-analysis also suggests for future larger studies with stratified case control population and biological characterization for validation studies.
    PLoS ONE 05/2013; 8(5):e64747. DOI:10.1371/journal.pone.0064747 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Studying gene-environment interactions may elucidate the complex origins of atopic diseases. The aim of this study was to evaluate the association of CD14 polymorphisms and atopy in Egyptian children and to study whether atopy is influenced by CD14 interaction with tobacco smoke exposure. CD14 -159 C/T and CD14 -550 C/T were genotyped in 500 asthmaic children, 150 allergic rhinitis children and 150 controls. We found that CD14 -159T allele, CD14 -550T allele and CD14 -159T/-550T haplotype were significantly associated with atopic asthma and allergic rhinitis groups. CD14 -159 TT and CD14 -550 TT genotypes associated with elevated IgE levels in children exposed to tobacco smoke. The TT genotype of CD14 -159 C/T and CD14 -550 C/T was associated with higher serum levels of sCD14. The present study indicated that CD14 gene polymorphisms may contribute to susceptibility to atopy in Egyptian children and influenced with tobacco smoke exposure.
    Cellular Immunology 08/2013; 285(1-2):31-37. DOI:10.1016/j.cellimm.2013.08.001 · 1.87 Impact Factor